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Background: An abscess is a pocket of pus that forms around the root of an infected 
tooth. In this study, we aimed to investigate the extracellular matrix proteases 
ADAMTS1, ADAMTS4, osteonectin, and osteopontin expressions in abscess fluid 
cells in jaws after implantation and prosthesis operation. 
Materials and methods: In this clinical study, abscess fluids belonging to 
17 patients who applied to the Department of Oral and Maxillofacial Surgery were 
examined histopathologically and immunohistochemically. In the histopathological 
examination of the abscess fluid, separation of chromatin bridges in the nuclei 
of neutrophil cells, pyknosis and apoptotic changes in the nucleus, degenerative 
change in the cytoplasm, and occasional vacuolar structures were observed. 
Results: The positive reaction of ADAMTS1 was observed in fibroblast cells, plasma 
cells, and macrophage cells. The positive reaction of ADAMTS4 was observed in 
fibroblast cells, osteoclast cells, and some apoptotic leukocyte cells. Osteopontin 
expression in osteoclastic cells and polymorphonuclear cells was defined as pos-
itive. Osteonectin expression was positive in polymorphonuclear leukocytes and 
hypertrophic fibroblast cells. 
Conclusions: ADAMTS1 and ADAMTS4 may induce bone destruction with its 
distinctive property in alveolar bone resorption, which promotes the activation 
of osteoclasts, which can accelerate the destruction of the extracellular matrix 
in the acute phase. Furthermore, osteoclastic activity increased with the increase 
of osteonectin and osteopontin protein expression due to inflammation in the 
abscess cases. (Folia Morphol 2019; 78, 4: 754–761)
Key words: tooth abscess, ADAMTS1, ADAMTS4, osteonectin, 
osteopontin
INTRODUCTION
The term tooth or dentoalveolar abscess is used 
to define the localised pus collection on the alveolar 
bone at the root apex. It usually occurs secondary 
to dental caries, trauma, deep fillings, or failed root 
canal treatment. After the chamber of untreated pa-
per clay has deteriorated, the colonisation of the root 
canals becomes apparent with a mixture of various 
bacteriological agents [45]. Lymphocytes act in any 
immunological reaction as they are in non-immuni-
tis. In chronic inflammation, there is a relationship 
between the T lymphocytes and macrophages, with 
activated T lymphocytes and macrophages acting on 
each other, causing both cells to become inflamed 
755
U.N. Yilmaz et al., Abscess fluid cells formed in maxillofacial area
mediators. Active lymphocytes secrete a series of 
chemical mediators. These are cytokines, the main 
stimulators of macrophages. Macrophages release 
interleukin-1 (IL-1) and tumour necrosis factor (TNF) 
containing cytokines. These also activate lympho-
cytes. The macrophages and T cells constantly stim-
ulate each other in the inflammatory focus from the 
antigen effect from the onset [37, 52].
An abscess is a collection of localised inflamma-
tion that causes the formation of pus in the tissue. 
It occurs when pyogenic bacteria are placed deep 
into the tissue. Focal accumulation of neutrophils 
starts abscess formation. Immediately, a band of 
dilate veins forms, and fibroblastic proliferation oc-
curs, which surrounds the abscess at the outermost 
limit of the abscess. After tooth extraction, alveolar 
bone resorption has been reported to significant-
ly reduce the residual bone volume, and implants 
that are required for optimal restoration can disrupt 
the proper position [16, 42, 48]. This situation is 
more pronounced in the front of the maxilla, and 
palate-labial indications occur during the implant 
and prosthesis operation. Immediate placement of 
the implants in the extraction sockets can prevent 
this unwanted resorption [41, 43]. A disintegrin 
and metalloproteinase with thrombospondin motifs 
(ADAMTS) proteases are secreted enzymes that act on 
a wide variety of extracellular matrix (ECM) substrates 
including pro-collagen, proteoglycans, hyalectans, 
and cartilage oligomeric matrix protein [14, 41]. The 
ADAMTS1 gene is responsive to inflammation that 
is not expressed in normal tissues, but it is induced 
by lipopolysaccharide stimulation [19]. The major 
enzymes ADAMTS4 and ADAMTS5 are involved in 
the degradation of the main proteoglycan agonist 
in articular cartilage and have been shown to be 
the target for therapeutic inhibition leading to the 
development of osteoarthritis [47].
Osteopontin (OPN) is a secreted phosphoprotein 
with various roles in the immune response. It is made 
by T cells and macrophages and binds to a series of 
integrins as an intact protein or as proteolytically 
cleaved fragments [14]. Moreover, OPN is expressed in 
various cell types and tissues, such as preosteoblasts, 
osteoblasts, osteocytes [6], fibroblasts [49], dendritic 
cells, macrophages, and T cells [22]. Osteonectin 
(ON) is a glycoprotein synthesised by the cells of an 
osteoblastic lineage, which is abundantly expressed 
in bones undergoing active remodelling. It binds hy-
droxyapatite, calcium, and type I collagen and inhibits 
mineralisation in vitro [18]. Classically, ON has been 
used to follow the progression of in vivo and in vitro 
osteoblast cytodifferentiation [2, 20, 24].
In this study, we aimed to investigate the ECM 
proteases ADAMTS1, ADAMTS4, ON and OPN expres-
sions in abscess fluid cells in jaws after implantation 
and prosthesis operation.
MATERIALS AND METHODS
Patient follow-up
In this clinical study, abscess fluids belonging to 
17 patients who applied to the Department of Oral 
and Maxillofacial Surgery were examined histopatho-
logically and immunohistochemically. This study was 
registered as a prospective clinical trial with the Dental 
Faculty Hospital Trial Registry. Informed consent was 
obtained from the patients before enrolment in the 
clinical evaluation. A written informed consent form 
was obtained from the parents of children younger 
than 18 years old.
Fine-needle aspiration cytology
Fine-needle aspiration was performed with 
a 20–25 gauge needle (Fig. 1). The abscess fluid that 
we obtained was conserved at +4°C. Then, the mate-
rials were sent to the histology laboratory for routine 
histological procedures. The abscess fluid was subject-
ed to high-speed centrifugation, the supernatant was 
discarded, and 10% (v/v) neutral formalin was added 
Figure 1. Fine-needle aspiration for abscess fluid formed in the 
submandibular area.
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(pellet to formalin volume ratio, 1:3). After 2 h of 
fixation, the clear bright supernatant was discarded, 
and the tube was inverted on filter paper to allow 
excess fluid to drain. The pellet was then placed on 
filter paper using a spatula, and eosin stain solution 
was added using a Pasteur pipette. After the cell 
aggregate developed a red colour, it was wrapped 
in filter paper and placed in a cassette, which was 
then stored in a fixation box for tissue processing. 
The cells were examined using Harris haematoxylin 
and eosin (H&E) staining. The abscess fluid was also 
immunostained and examined under Olympus BH-2 
light microscopy.
Haematoxylin and eosin staining procedure
1. Deparaffinize sections, two changes of xylene, 
10 min each.
2. Re-hydrate in two changes of absolute alcohol, 
5 min each.
3. 95% alcohol for 2 min and 70% alcohol for 2 min.
4. Wash briefly in distilled water.
5. Stain in Harris haematoxylin solution for 8 min.
6. Wash in running tap water for 5 min.
7. Differentiate in 1% acid alcohol for 30 s.
8. Wash running tap water for 1 min.
9. Bluing in 0.2% ammonia water or saturated 
lithium carbonate solution for 30 s to 1 min.
10. Wash in running tap water for 5 min.
11. Rinse in 95% alcohol, 10 dips.
12. Counterstain in eosin-phloxine solution for 30 s 
to 1 min.
13. Dehydrate through 95% alcohol, two changes of 
absolute alcohol, 5 min each.
14. Clear in two changes of xylene, 5 min each.
15. Mount with xylene based mounting medium.
Immunohistochemical staining
Sections of abscess fluid cells were brought to 
distilled water and washed in 3 × 5 min phosphate 
buffered saline (PBS; catalogue number 10010023, 
Thermo Fischer Scientific Fremont, CA, USA). Antigen 
retrieval was done in a microwave (Bosch®, 700 watt) 
for 3 min at 90oC. They were subjected to a heating 
process in a microwave oven at 700 watts in a citrate 
buffer (pH 6) solution for proteolysis. Sections were 
washed in 3 × 5 min PBS and incubated with hydro-
gen peroxide [K-40677109,64271 hydrogen peroxide 
(H2O2) Dortmund, Germany, Merck] (3 mL 30% H2O2 
+ 27 mL methanol) for 20 min. Sections were washed 
in 3 × 5 min PBS and blocked with ultra v block (lot: 
PHL150128, Thermo Fischer, Fremont, CA, USA) for 
8 min. After draining, the primary antibodies were 
directly applied to the sections, namely, ADAMTS1 
monoclonal antibody 1:100, ADAMTS4 monoclo-
nal antibody 1:100, ON monoclonal antibody 1:100, 
and OPN monoclonal antibody 1:100. Sections were 
incubated and left overnight at 4oC. Sections were 
washed in 3 × 5 min PBS and then incubated with 
biotinylated secondary antibody (lot: PHL150128, 
Thermo Fischer, Fremont, CA, USA) for 14 min. Af-
ter washing with PBS, streptavidin peroxidase (lot: 
PHL150128, Thermo Fischer, Fremont, CA, USA) was 
applied to the sections for 15 min. The sections were 
washed in 3 × 5 min PBS, and DAB (lot: HD36221, 
Thermo Fischer, Fremont, CA, USA) was applied to 
sections for up to 10 min. Slides showing a reaction 
were stopped in PBS. Counterstaining was done with 
Harris’s haematoxylin for 45 s, dehydrated through 
ascending alcohol and cleared in xylene (product 
number: HHS32 Sigma, haematoxylin solution, Har-
ris modified, Sigma-Aldrich, Saint Louis, MO, USA). 
Slides were mounted with Entellan® (lot: 107961, 
Sigma-Aldrich, St. Louis, MO, USA) and examined 
under Olympus BH-2 light microscopy.
Semi-quantitative score  
of histopathologic parameters 
Semi-quantitative score was determined by exam-
ining chromatin bridges breakage in nucleus of neu-
trophil cells, apoptotic changes in nucleus of lekocyte 
cells, vacuolar structures in leukocyte cells, ADAMTS1 
expression in fibroblast cells, ADAMTS4 expression in 
fibroblast cells, OPN expression in polimorph nucleus 
of leukocyte cells, and ON expression in osteoclast 
cells in the histological sections of abscess fluid. Mi-
croscopic examination of these parameters was per-
formed in 15 different fields and counting 10 cells in 
each area (Tables 1 and 2).
Statistical analysis  
Statistical analysis was performed using SPSS 21.0 
for Windows statistical package. Statistical analysis 
was performed with mean ± standard deviation and 
categorical variables were presented with number and 
per cent. Chi-square test was used for comparison 
of qualitative variables between groups. Hypotheses 
were biased. P ≤ 0.05, a statistically significant result 
was considered.
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RESULTS
Statistical findings
Statistical results of histopathological parameters 
are given in Tables 1 and 2 in detail.
Histological findings
In the histopathological examination of the ab-
scess fluid, we observed separation of chromatin 
bridges in the nuclei of neutrophil cells, pyknosis 
and apoptotic changes in the nucleus, degenerative 
change in the cytoplasm, and occasional vacuolar 
structures. The nucleus size in lymphocytes is normally 
close to that of the cytoplasm, while nuclear shrink-
age and cytoplasm are larger due to infection (Fig. 2).
Immunohistochemical findings
A positive reaction of ADAMTS1 was observed in 
fibroblast cells, plasma cells, and macrophage cells 
(Fig. 3). In addition, a positive reaction of ADAMTS4 
was observed in fibroblast cells, osteoclast cells, and 
some apoptotic leukocyte cells (Fig. 4). The expression 
of OPN in osteoclastic cells and polymorphonuclear 
cells was defined as positive (Fig. 5). The expression of 
ON was positive in polymorphonuclear leukocytes and 
hypertrophic fibroblast cells. In the periapical abscess, 
oedema and hyperaemia occur due to the infiltration 
of periodontal membrane inflammation cells in the 
root tip. Bone resorption occurs with inflammation 
in the mouth (Fig. 6).
DISCUSSION
In this clinical study, we examined immunohisto-
chemical expressions of ADAMTS1, ADAMTS4, ON, 
and OPN proteins in abscess fluid cells formed during 
surgical procedures applied to implant or prosthetic 
patients. In the literature review, we did not find 
a scientific study showing the relationship between the 
expressions of these proteins and abscess fluid cells. 
Immunohistochemical cross sections of these proteins 
in the abscess fluid were shown in detail (Figs. 2–6).
The formation of periradicular lesions involves 
inflammatory cell infiltration, necrosis, abscess for-
mation, apical periodontal ECM degradation, and 
resorption of root and alveolar bone as the result 
Table 2. Semi-quantitative score of histopathological parameters in patients
Scores (0–4)  
in patients
Parameters — N (%)
Chromatin 
bridges 
breakage in 
nucleus of 
neutrophil 
cells
Apoptotic 
changes in 
nucleus of 
leukocyte 
cells
Vacuolar 
structures 
in leukocyte 
cells
ADAMTS1 
expression 
in fibroblast 
cells
ADAMTS4 
expression 
in fibroblast 
cells
Osteopontin 
expression 
in polymorph 
nucleus of 
leukocyte 
cells
Osteonectin 
expression 
in osteoclast 
cells
Total
0–2 0 (0%) 2 (20.0%) 2 (20.0%) 2 (20.0%) 0 (0%) 3 (30.0%) 1 (10.0%) 10 (100%)
3 8 (12.7%) 10 (15.9%) 10 (15.9%) 11 (17.5%) 5 (7.9%) 10 (15.9%) 9 (14.3%) 63 (100%)
4 9 (19.6%) 5 (10.9%) 5 (10.9%) 4 (8.7%) 12 (26.1%) 4 (8.7%) 7 (15.2%) 46 (100%)
Total — Count (%) 17 (14.3%) 17 (14.3%) 17 (14.3%) 17 (14.3%) 17 (14.3%) 17 (14.3%) 17 (14.3%) 119 (100%)
The quantification of all parameters: 0 — no change, 1 — too weak, 2 — weak, 3 — middle, 4 — strong. Scoring was determined by examining histological parameters in 15 different 
regions within the microscope field, and 10 cells counted in each area
Table 1. Valid and cumulative per cent of histopathological parameters
Histopathological parameters Patient (n) Per cent Valid per cent Cumulative per cent
Chromatin bridges breakage in nucleus of neutrophil cells 17 14.3 14.3 14.3
Apoptotic changes in nucleus of leukocyte cells 17 14.3 14.3 28.6
Vacuolar structures in leukocyte cells 17 14.3 14.3 42.9
ADAMTS1 expression in fibroblast cells 17 14.3 14.3 57.1
ADAMTS4 expression in fibroblast cells 17 14.3 14.3 71.4
Osteopontin expression in polymorph nucleus of leukocyte cells 17 14.3 14.3 85.7
Osteonectin expression in osteoclast cells 17 14.3 14.3 100.0
Total 119 100.0 100.0
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of continuous stimulation from bacteria in the root 
canal [50]. Clinical practices have indicated that per-
iodontal, endodontic, and implant-phase infection is 
an important predictor of implant development and 
reduces the chances for successful implant placement 
[3, 17, 29, 34, 35]. The goal of implant therapy is to 
improve the quality of life of patients by allowing the 
removal of removable dentures and reducing the bur-
den on sensitive soft tissues. Periapical implant lesions 
show a pathological osteolysis area at the apex of the 
osseointegrated implant [8, 30–32]. Contamination 
of implants may be explained by the presence of ne-
crotic and traumatised bone tissue and/or impaired 
host defence mechanisms. The detection of enzymes 
from polymorphonuclear granulocytes (PMN) at high 
concentrations in peri-implanted regions may indicate 
Figure 2. Haematoxylin-eosin staining. Separation of chromatin 
bridges in the nuclei of neutrophil cells (white arrows) and degener-
ative changes and apoptosis in some leukocyte cells (blue arrow). 
Scale bar = 50 μm.
Figure 6. Osteonectin (ON) immunostaining. Positive ON expression 
in polymorphonuclear leukocytes (red arrow) and hypertrophic 
fibroblast cells (yellow arrow). Scale bar = 50 μm.
Figure 3. ADAMTS1 immunostaining. Positive expression of 
ADAMTS1 in fibroblast cells (yellow arrow), plasma cells (black 
arrow), and macrophage cells (blue arrow). Scale bar = 50 μm.
Figure 4. ADAMTS4 immunostaining. Positive expression of  
ADAMTS4 in fibroblast cells (yellow arrow), osteoclast cells  
(green arrow), and some apoptotic leukocyte cells (red arrow). 
Scale bar = 50 μm.
Figure 5. Osteopontin (OPN) immunostaining. Positive OPN expres-
sion in osteoclastic cells (green arrow) and degenerative polymor-
phonuclear cells (red arrow). Scale bar = 50 μm.
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increased PMN cell activity [4]. A high number of PMN 
cells associated with a significant amount of mucosal 
inflammation around the implants have been identi-
fied [36]. A few histopathological and immunohisto-
chemical analyses of the peri-implantitis indications of 
the tissues surrounding the implants, namely clinical 
signs of inflammation, revealed advanced bone loss 
and the presence of large inflammatory cell infiltrates 
[9, 12, 21, 33]. Esposito et al. [9] analysed the prop-
erties of soft tissues surrounding implants that fail 
immunohistochemically. They reported that a mar-
ginal portion of the specimens was characterised by 
intense inflammation and immunological responses. 
Demircan et al. [7] reported that the ADAMTS enzyme 
levels and activities should be illuminated at both the 
protein and mRNA levels of tissue inhibitor proteins 
in bone formation. Moreover, ADAMTS8 is released 
from neutrophils or macrophages during the acute 
phase of lesion formation and promotes the forma-
tion and activation of osteoclasts [11]. In addition, 
ADAMTS1 and ADAMTS4 may play an important role 
in aortic inflammation. Inflammatory cells such as 
macrophages play critical roles in the progression of 
aortic aneurysms by producing proinflammatory cy-
tokines and proteolytic enzymes [44]. The ADAMTS1 
and ADAMTS4 proteins may support tissue destruc-
tion and disease formation by various mechanisms. 
Mimata et al. [26] found that ADAMTS4 expression is 
upregulated in fibroblast-like synoviocytes in patients 
with IL-6 rheumatoid arthritis. It has been indicated 
that IL-6 it may induce ADAMTS4 expression from 
fibroblast-like synoviocytes in cartilage destruction in 
rheumatoid arthritis. In our study of ADAMTS1 and 
ADAMTS4 immunohistochemical analysis, fibroblast 
cells, macrophage cells, and some apoptotic leuco-
cytes as well as ADAMTS1 and ADAMTS4 expressions 
in osteoclast cells were positive. It was thought that 
ADAMTS1 and ADAMTS4 may be predictive of the 
modulation of inflammation and bone metabolism 
as well as tissue damage, including alveolar bone 
resorption and the development of gingival lesions 
in the early phase after prosthetic and implant oper-
ations. Several recent studies have demonstrated the 
effect of cytokines, such as IL-beta, TNF-alpha, and 
transforming growth factor-beta on the expression 
of ADAMTS4 and ADAMTS5 in fibroblast-like synovi-
ocytes [13, 26, 53].
Moreover, OPN is induced in macrophages by 
several inflammatory cytokines including TNF-alpha, 
IL-1p, interferon-gamma (IFN-gamma), and IL-6. Other 
factors, such as angiotensin-II, oxidised low-density 
lipoprotein, and phorbol-ester, are inducers of OPN 
[5, 27, 28]. In addition, OPN changes chronic inflam-
matory responses. Chronic inflammation is charac-
terised by the persistence of injury to macrophages 
and disease sites [22]. During cell-mediated immune 
responses against bacterial and viral pathogens, OPN 
plays a pivotal role in T cell and macrophage respons-
es [1]. Moreover, OPN has been shown to downregu-
late IL-10. It is thought to increase bone destruction 
associated with endodontic infections [39].
Additionally, ON is a non-collagenous protein of 
the bone matrix that is quite ubiquitously expressed 
[25, 51]. Moreover, ON has also been observed in 
bovine odontoblasts [10, 15] and in odontoblasts and 
predentin in human prenatal and postnatal samples 
[38]. This extracellular distribution may be related to 
the specific polarised tissue organisation where only 
the odontoblast process is included in the mineralised 
matrix [40]. On the other hand, the cellular processes 
of ON-producing odontoblasts are in contact with 
mechanical stresses, heat shocks, and cariogenic bac-
teria products [23, 46]. Our data also suggest that 
ON expression increased due to bone tissue damage.
Despite the results, there are a few limitations. 
When the histopathological parameters were evalu-
ated statistically in a total of 17 patients in according 
to semi-quantitative score, the remarkable results are 
as follows:
 — no patient was found to break the chromatin 
bridges in the nucleus of neutrophil cells. But, this 
deformity was prominent in 9 patients;
 — apoptotic changes in leukocyte cell nuclei, vacuo-
lar structures in leukocyte cells, and osteopontin 
expression in polymorph nucleus of leukocyte cells 
were moderate in ten patients;
 — ADAMTS1 expression in fibroblast cells was prom-
inent in eleven patients;
 — ADAMTS4 expression in fibroblast cells was prom-
inent in twelve patients;
 — osteonectin expression in osteoclast cells was 
moderate in 9 patients.
When these parameters were evaluated cumula-
tively; remarkable protein expression results are as 
follows:
 — osteopontin expression in osteoclast cells was 
seen in all patients;
 — osteopontin expression was detected in poly-
morphous nuclei of leukocyte cells in 85.7% of 
patients;
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 — ADAMTS4 expression was detected in fibroblast 
cells in 71.4% of patients;
 — ADAMTS1 expression was detected in fibroblast 
cells in 57.1% of patients.
CONCLUSIONS
We consider that ADAMTS1 and ADAMTS4 may 
induce bone destruction with their distinctive prop-
erty of alveolar bone resorption, which promotes 
the activation of osteoclasts, which can accelerate 
the destruction of ECM in the acute phase. In cases 
of acute and chronic abscesses, ON and OPN protein 
increases were observed in osteocyte cells due to 
maxilla and mandibular bone tissue damage. Bone 
destruction was also thought to be induced due to 
a marked increase in osteoclast activity.
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